Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 14, 2019
Adverse Events Associated with the Use of Guide Extension Catheters during Percutaneous Coronary Intervention: Reports from the Manufacturer and User Facility Device Experience (MAUDE) databaseYuefeng Chen, Arhum A Shah, Evan Shlofmitz, et al.
Marine Drugs|July 27, 2022
Therapeutic Potential of Marine Bioactive Peptides against Human Immunodeficiency Virus: Recent Evidence, Challenges, and Future TrendsJameel Mohammed Al-Khayri, Waqas Asghar, Sipper Khan, et al.
International Journal of Cardiology|August 9, 2021
Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study)Evan Shlofmitz, Rebecca Torguson, Cheng Zhang, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 6, 2019
Formulation of active packaging system using Artemisia scoparia for enhancing shelf life of fresh fruitsJavaria Hanif, Nauman Khalid, Rao Sanaullah Khan, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 10, 2019
Techniques to Optimize the Use of Optical Coherence Tomography: Insights from the Manufacturer and User Facility Device Experience (MAUDE) DatabaseEvan Shlofmitz, Hector M Garcia-Garcia, Toby Rogers, et al.
The American Journal of Cardiology|September 1, 2021
High-Risk Percutaneous Coronary Intervention of Native Coronary Arteries Without Mechanical Circulatory Support in Acute Coronary Syndrome Without Cardiogenic ShockNauman Khalid, Cheng Zhang, Corey Shea, et al.
American Heart Journal|January 18, 2020
Impact of Intravascular Ultrasound on Outcomes Following PErcutaneous Coronary InterventioN in Complex Lesions (iOPEN Complex)Evan Shlofmitz, Rebecca Torguson, Cheng Zhang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 30, 2019
Real-World Experience of the Sentinel Cerebral Protection Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) DatabaseBrian C Case, Brian J Forrestal, Charan Yerasi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 6, 2021
Real-World Experience of the MANTA Closure Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) DatabaseBrian C Case, Charan Yerasi, Brian J Forrestal, et al.
Circulation. Cardiovascular Interventions|June 7, 2021
Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory SupportNauman Khalid, Toby Rogers, Rebecca Torguson, et al.
Pageof 14